TY - JOUR
T1 - Simultaneous submission of seven CTSA proposals
T2 - UM1, K12, R25, T32-predoctoral, T32-postdoctoral, and RC2: Strategies, evaluation, and lessons learned
AU - Lema, Carolina
AU - Cheng, Kwai Wa
AU - Anderson, Delanderia M.
AU - Miller, Charles C.
AU - Karp, Daniel D.
AU - McPherson, David D.
AU - Kolar, Satya Sree N.
N1 - Publisher Copyright:
© The Author(s), 2024. Published by Cambridge University Press on behalf of Association for Clinical and Translational Science.
PY - 2024/1/25
Y1 - 2024/1/25
N2 - Translation is the process of turning observations in the research laboratory, clinic, and community into interventions that improve people's health. The Clinical and Translational Science Awards (CTSA) program is a National Center for Advancing Translational Sciences (NCATS) initiative to advance translational science and research. Currently, 64 CTSA hubs exist across the nation. Since 2006, the Houston-based Center for Clinical Translational Sciences (CCTS) has assembled a well-integrated, high-impact hub in Texas that includes six partner institutions within the state, encompassing ∼23,000 sq. miles and over 16 million residents. To achieve the NCATS goal of more treatments for all people more quickly, the CCTS promotes diversity and inclusion by integrating underrepresented populations into clinical studies, workforce training, and career development. In May 2023, we submitted the UM1 application and six companion proposals: K12, R25, T32-Predoctoral, T32-Postdoctoral, and RC2 (two applications). In October 2023, we received priority scores for the UM1 (22), K12 (25), T32-Predoctoral (20), and T32-Postdoctoral (23), which historically fall within the NCATS funding range. This report describes the grant preparation and submission approach, coupled with data from an internal survey designed to assimilate feedback from principal investigators, writers, reviewers, and administrative specialists. Herein, we share the challenges faced, the approaches developed, and the lessons learned.
AB - Translation is the process of turning observations in the research laboratory, clinic, and community into interventions that improve people's health. The Clinical and Translational Science Awards (CTSA) program is a National Center for Advancing Translational Sciences (NCATS) initiative to advance translational science and research. Currently, 64 CTSA hubs exist across the nation. Since 2006, the Houston-based Center for Clinical Translational Sciences (CCTS) has assembled a well-integrated, high-impact hub in Texas that includes six partner institutions within the state, encompassing ∼23,000 sq. miles and over 16 million residents. To achieve the NCATS goal of more treatments for all people more quickly, the CCTS promotes diversity and inclusion by integrating underrepresented populations into clinical studies, workforce training, and career development. In May 2023, we submitted the UM1 application and six companion proposals: K12, R25, T32-Predoctoral, T32-Postdoctoral, and RC2 (two applications). In October 2023, we received priority scores for the UM1 (22), K12 (25), T32-Predoctoral (20), and T32-Postdoctoral (23), which historically fall within the NCATS funding range. This report describes the grant preparation and submission approach, coupled with data from an internal survey designed to assimilate feedback from principal investigators, writers, reviewers, and administrative specialists. Herein, we share the challenges faced, the approaches developed, and the lessons learned.
KW - CCTS
KW - CTSA
KW - grant writing
KW - PAR-21-293
KW - UM1
UR - http://www.scopus.com/inward/record.url?scp=85183529567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183529567&partnerID=8YFLogxK
U2 - 10.1017/cts.2024.14
DO - 10.1017/cts.2024.14
M3 - Article
C2 - 38384924
AN - SCOPUS:85183529567
SN - 2059-8661
VL - 8
JO - Journal of Clinical and Translational Science
JF - Journal of Clinical and Translational Science
IS - 1
M1 - e33
ER -